Ergoteles LLC Charles River Laboratories International, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $2.48 Million - $2.84 Million	-13,519 Reduced 89.6%	1,569 $329,000
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $1.04 Million - $1.41 Million	5,433 Added 56.27%	15,088 $3.05 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $1.9 Million - $2.41 Million	9,655 New	9,655 $2.1 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $461,706 - $654,332	-1,807 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $634,943 - $810,764	1,807 New	1,807 $681,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.